Form 4 for AGL agilon health, inc.
Accepted 2022-08-12 00:00:00 ET · period of report 2022-08-10 · accession 0001209191-22-045617 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-12 | 2022-08-10 | AGL | Schwaneke Jeffrey A. | Dir | A - Grant | $0.00 | +4,009 | 4,009 | New | $0 |
| D | 2022-08-12 | 2022-08-10 | AGL | Schwaneke Jeffrey A. | Dir | A - Grant | $0.00 | +9,680 | 9,680 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-10 | A | A | 4,009 | $0.00 | 4,009 | D | — | — | (F1) Restricted stock units that vest in full on August 10, 2023, subject to continued service as a director. |
| 2 | Derivative | Options (Rights to Buy) | 2022-08-10 | A | A | 9,680 | $0.00 | 9,680 | D | $27.01 · — to 2032-08-10 | 9,680 Common Stock | (F2) Options that vest in three equal installments on each anniversary of August 10, 2022, subject to continued service as a director. |